FDA Advisory Panel Endorses Approval of Alzheimerβs Drug Made by Eli Lilly NYT: Science Gina Kolata and Pam Belluck 10 June 2024 at 17:05 The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.